Weight and weight change and risk of atrial fibrillation: the HUNT study.


Journal

European heart journal
ISSN: 1522-9645
Titre abrégé: Eur Heart J
Pays: England
ID NLM: 8006263

Informations de publication

Date de publication:
07 09 2019
Historique:
received: 29 11 2018
revised: 26 02 2019
accepted: 22 05 2019
pubmed: 19 6 2019
medline: 18 11 2020
entrez: 19 6 2019
Statut: ppublish

Résumé

Although obesity has been associated with risk of atrial fibrillation (AF), the associations of long-term obesity, recent obesity, and weight change with AF risk throughout adulthood are uncertain. An ambispective cohort study was conducted which included 15 214 individuals. The cohort was created from 2006 to 2008 (the baseline) and was followed for incident AF until 2015. Weight and height were directly measured at baseline. Data on previous weight and height were retrieved retrospectively from measurements conducted 10, 20, and 40 years prior to baseline. Average body mass index (BMI) over time and weight change was calculated. During follow-up, 1149 participants developed AF. The multivariable-adjusted hazard ratios were 1.2 (95% confidence interval 1.0-1.4) for average BMI 25.0-29.9 kg/m2 and 1.6 (1.2-2.0) for average BMI ≥30 kg/m2 when compared with normal weight. The association of average BMI with AF risk was only slightly attenuated after adjustment for most recent BMI. In contrast, current BMI was not strongly associated with the risk of AF after adjustment for average BMI earlier in life. Compared with stable BMI, both loss and gain in BMI were associated with increased AF risk. After adjustment for most recent BMI, the association of BMI gain with AF risk was largely unchanged, while the association of BMI loss with AF risk was weakened. Long-term obesity and BMI change are associated with AF risk. Obesity earlier in life and weight gain over time exert cumulative effects on AF development even after accounting for most recent BMI.

Identifiants

pubmed: 31209455
pii: 5519674
doi: 10.1093/eurheartj/ehz390
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2859-2866

Commentaires et corrections

Type : CommentIn

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Auteurs

Tingting Feng (T)

Department of Public Health and Nursing, Norwegian University of Science and Technology, Mauritz Hanssens gate 2, NO-7489 Trondheim, Norway.

Malmo Vegard (M)

Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Prinsesse Kristinas gate 3, Postboks 8905, Trondheim, Norway.
Department of Cardiology, St. Olavs Hospital, Prinsesse Kristinas gate 3, Postboks 3250, Trondheim, Norway.

Linn B Strand (LB)

Department of Public Health and Nursing, Norwegian University of Science and Technology, Mauritz Hanssens gate 2, NO-7489 Trondheim, Norway.

Lars E Laugsand (LE)

Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Prinsesse Kristinas gate 3, Postboks 8905, Trondheim, Norway.
Department of Cardiology, St. Olavs Hospital, Prinsesse Kristinas gate 3, Postboks 3250, Trondheim, Norway.

Bjørn Mørkedal (B)

Department of Cardiology, Vestfold Hospital Trust, Halfdan Wilhelmsens alle 17, Postboks 2168, Tønsberg, Norway.

Dagfinn Aune (D)

Department of Epidemiology and Biostatistics, Imperial College London, South Kensington, London, UK.
Department of Nutrition, Bjørknes University College, Lovisenberggata 13, Oslo, Norway.
Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Trondheimsveien 235, OUS Aker, Oslo, Norway.

Lars Vatten (L)

Department of Public Health and Nursing, Norwegian University of Science and Technology, Mauritz Hanssens gate 2, NO-7489 Trondheim, Norway.

Hanne Ellekjær (H)

Stroke Unit, Department of Internal Medicine, St Olav's Hospital, Harald Hardrådes gate 14, Trondheim, Norway.
Department of Neuromedicine and Movement Science, Norwegian University of Science and Technology, Edvard Griegs gate 8, N-7491 Trondheim, Norway.

Jan P Loennechen (JP)

Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Prinsesse Kristinas gate 3, Postboks 8905, Trondheim, Norway.
Department of Cardiology, St. Olavs Hospital, Prinsesse Kristinas gate 3, Postboks 3250, Trondheim, Norway.

Kenneth Mukamal (K)

Department of Medicine, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA, USA.

Imre Janszky (I)

Department of Public Health and Nursing, Norwegian University of Science and Technology, Mauritz Hanssens gate 2, NO-7489 Trondheim, Norway.
Department of Neurology, Medical School, University of Pécs, Rét u. 2, 7623 Pécs, Hungary.
Institute of Behavioural Sciences, Semmelweis University, Nagyvárad tér 4, H-1089 Budapest, Hungary.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH